Vireo Growth Inc (VREOF) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to Vireo Growth Inc's Q1 2026 results call. The company would like to remind everyone that today's conference call may contain forward-looking statements within the meaning of U.S. and Canadian securities laws. These statements are based on management's current expectations and involve risks and uncertainties that could differ materially from actual events and those described in such forward-looking statements. For more information on forward-looking statements, please refer to forward-looking statement disclosure in the company's earnings release. This call may also contain non-GAAP financial measures. Please see our earnings release for reconciliations to GAAP measures. I'll now hand the call over to Chief Executive Officer John Mazarrakis. Thank you. Good morning, everyone. Over the past several months, we've closed SchwarzEase, Hawthorne, and the Pharmacan MSA, adding over $100 million of quarterly revenue to our top line. The results are transformative, as we're now the fourth largest cannabis company by revenue on a pro forma basis. We now operate in 10 states with over 160 dispensaries and hold leading positions as the largest operator in Colorado, Utah, and Nevada, along with meaningful market share in Minnesota and Missouri. We also announced two additional transactions, Fluent and Glasshouse. The Glasshouse partnership brings together Vireo's retail and delivery ease infrastructure with Glasshouse's large-scale, low-cost production. This creates a scaled retail platform designed to improve operating efficiency and expand consumer access in the world's largest legal cannabis market, California. The Fluent opportunity expands our presence in one of the most important cannabis markets in the country. Florida's limited license structure...